Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Director's Dealing 2022

Jun 7, 2022

3535_dirs_2022-06-07_56a58c3d-26aa-4df6-b5be-d53503129677.html

Director's Dealing

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - EXERCISE OF SHARE OPTIONS UNDER INCENTIVE PROGRAM

AQUA BIO TECHNOLOGY ASA - EXERCISE OF SHARE OPTIONS UNDER INCENTIVE PROGRAM

7.6.2022 18:29:01 CEST | Aqua Bio Technology ASA | Mandatory notification of

trade primary insiders

Aqua Bio Technology ASA's ("ABT" or the "Company") board of directors has today

pursuant to a board authorization granted by the general meeting on 9 June 2021

resolved a private placement towards the board members Kristin Aase and Tone

Bjørnov (the "Subscribers") in connection with the Subscribers' exercise of

25,000 share options each at a subscription price of NOK 7 per new share. All

the exercised options have been granted in accordance with the Company's share

option program as described in the Company's latest annual financial statements.

Following the subscription of the new shares Kristin Aase holds directly and

indirectly, through being a close associate with Kjeveortoped Espen Dahl AS,

1,459,707 shares in the Company, whereas Tone Bjørnov holds 153,203 shares in

the Company.

This information is subject to the disclosure requirements in Regulation EU

596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

* * *

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941

32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on the Euronext Expand market

of the Oslo Stock Exchange.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1518/2078/Download%20announcement

%20as%20PDF.pdf

Notification form Kristin Aase.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1518/2076/Notification%20form%20K

ristin%20Aase.pdf

Notification form Tone Bjornov.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/1518/2077/Notification%20form%20T

one%20Bjornov.pdf